Bio Sequence

Biological Glossary | What is Variant?

24 January 2024
2 min read

In biology, a variant refers to a specific region of the genome that differs between two genomes, or an individual organism with characteristics that deviate from the standard within a species. It is an alteration or mutation in an organism's genetic sequence. Variants can occur naturally or be induced for research purposes and can impact physical traits, disease susceptibility, or response to medication. 

Free registration is available for the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your sequence search tasks.

图片包含 图示

描述已自动生成

GALDERMA 2024: Phase III RelabotulinumtoxinA Trials Show Promising Results for Treating Facial Lines
Latest Hotspot
3 min read
GALDERMA 2024: Phase III RelabotulinumtoxinA Trials Show Promising Results for Treating Facial Lines
24 January 2024
GALDERMA 2024: Phase III trials of RelabotulinumtoxinA show favorable outcomes and extended effectiveness in addressing both glabellar lines and lateral canthal lines at once.
Read →
Aviceda Therapeutics Reports Promising Early Data from AVD-104 Study in Geographic Atrophy
Latest Hotspot
4 min read
Aviceda Therapeutics Reports Promising Early Data from AVD-104 Study in Geographic Atrophy
24 January 2024
Aviceda Therapeutics Reveals Preliminary Results from Initial Segment of Phase 2/3 SIGLEC Study on AVD-104, Indicating Encouraging Safety Profile and Initial Efficacy Signals in Individuals with Geographic Atrophy.
Read →
Aruna Bio's AB126 exosome therapy has gained FDA approval for its IND application
Latest Hotspot
3 min read
Aruna Bio's AB126 exosome therapy has gained FDA approval for its IND application
24 January 2024
Aruna Bio has received FDA approval for its investigational new drug (IND) application, allowing AB126, its pioneering exosome therapy.
Read →
Sarepta's EMERGENE Phase 3 Trial on SRP-9003 for LGMD 2E/R4 Begins Participant Enrollment
Latest Hotspot
3 min read
Sarepta's EMERGENE Phase 3 Trial on SRP-9003 for LGMD 2E/R4 Begins Participant Enrollment
22 January 2024
Sarepta Therapeutics Launches Participant Selection for Phase 3 Trial, EMERGENE, Investigating SRP-9003 in Limb-Girdle Muscular Dystrophy 2E/R4 Treatment.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.